Skip to main content

Table 1 Characteristics of study participants (n = 114)

From: Effectiveness of a digital medication event reminder and monitor device for patients with tuberculosis (SELFTB): a multicenter randomized controlled trial

Variables

Categories

f (%)

Arm

 

Intervention f (%)

Control f (%)

Gender

Female

40 (35.1)

18 (31.6)

22 (38.6)

Male

74 (64.9)

39 (68.4)

35 (61.4)

Marital status

Never

54 (47.4)

27 (47.4)

27 (47.4)

Married

51 (44.7)

29 (50.9)

22 (38.6)

Widowed

2 (1.8)

0 (0)

2 (3.5)

Divorced

7 (6.1)

1 (1.8)

6 (10.5)

Occupation status

No job

23 (20.2)

10 (17.5)

13 (22.8)

Student

4 (3.5)

4 (7.0)

0 (0)

Farmer

1 (0.9)

0 (0)

1 (1.8)

Trader

10 (8.8)

5 (8.8)

5 (8.8)

Housewife

9 (7.9)

2 (3.5)

7 (12.3)

Government employee

10 (8.8)

5 (8.8)

5 (8.8)

Daily laborer

45 (39.5)

22 (38.6)

23 (40.4)

Other

12 (10.5)

9 (15.8)

3 (5.3)

Highest level of education

No formal education

9 (7.9)

3 (5.3)

6 (10.5)

Primary

44 (38.6)

25 (43.9)

19 (33.3)

Secondary

30 (26.3)

14 (24.6)

16 (28.1)

Preparatory

11 (9.6)

5 (8.8)

6 (10.5)

University diploma

9 (7.9)

4 (7.0)

5 (8.8)

University diploma or above

11 (9.6)

6 (10.5)

5 (8.8)

Residential status

Lives alone

14 (12.3)

6 (10.5)

8 (14.0)

Lives with family

84 (73.7)

43 (75.4)

41 (71.9)

Lives with friends

7 (6.1)

3 (5.3)

4 (7.0)

Homeless

6 (5.3)

3 (5.3)

3 (5.3)

Other

3 (2.6)

2 (3.5)

1 (1.8)

Number of cohabitants

≤ 3

67 (58.8)

36 63.2)

31 (54.4)

4–6

38 (33.3)

17 (29.8)

21 (36.8)

7–9

7 (6.1)

2 (3.5)

5 (8.8)

≥ 10

2 (1.8)

2 (3.5)

0 (0)

Bedrooms

1

72 (63.2)

37 (64.9)

35 (61.4)

2

30 (26.3)

14 (24.6)

16 (28.1)

3

7 (6.1)

4 (7.0)

3 (5.3)

≥ 4

5 (4.4)

2 (3.5)

3 (5.3)

Household head

Yes

63 (55.3)

33 (57.9)

30 (52.6)

No

51 (44.7)

24 (42.1)

27 (47.4)

Residency status

Permanent

92 (80.7)

43 (75.4)

49 (85.9)

Temporary

22 (19.3)

14 (24.6)

8 (14.0)

Smoking per day

Never

94 (82.5)

50 (87.7)

44 (77.2)

1–5

19 (16.7)

6 (10.5)

13 (22.8)

6–10

1 (0.9)

1 (1.8)

0 (0)

Khat (a stimulant)

Never

91 (79.8)

47 (82.5)

44 (77.2)

1/week

10 (8.8)

3 (5.3)

7 (12.3)

> = 2/week

9 (7.9)

5 (8.8)

4 (7.0)

1/month

4 (3.5)

2 (3.5)

2 (3.6)

Alcohol

Never

72 (63.2)

40 (70.2)

32 (56.1)

> 1/day

12 (10.5)

5 (8.8)

7 (12.3)

2–5/day

19 (16.7)

7 (12.3)

12 (21.1)

≥ 6/day

3 (2.6)

1 (1.8)

2 (3.5)

Rarely

8 (7.0)

4 (7.0)

4 (7.0)

HIVa

Negative

96 (85.0)

47 (82.5)

49 (87.5)

Positive

17 (15.0)

10 (17.5)

7 (12.5)

On antiretroviral (If HIV positive)

Yes

12 (73.3)

7 (70.0)

5 (71.4)

No

5 (26.7)

3 (30.0)

2 (28.6)

TB treatment

New

102 (89.5)

50 (87.7)

52 (91.2)

Relapse

12 (10.5)

7 (12.3)

5 (8.8)

Place of diagnosis

Study facility

78 (68.4)

36 (63.2)

42 (73.7)

Health center

4 (3.5)

2 (3.5)

2 (3.5)

Public hospital

10 (8.8)

8 (14.0)

2 (3.5)

Private clinic/hospital

21 (18.4)

10 (17.5)

11 (19.3)

Other

1 (0.9)

1 (1.8)

0 (0)

TB test methodology

Microscopy

44 (38.6)

18 (31.6)

26 (45.6)

Xpert MTB/RIF

70 (61.4)

39 (68.4)

31 (54.4)

Microscopy result (if test with microscopy)b

1–9 (scanty)

1 (2.4)

0 (0)

1 (4.0)

1+

10 (23.8)

5 (29.4)

5 (20.0)

2+

15 (35.7)

10 (58.8)

5 (20.0)

3+

16 (38.1)

2 (11.8)

14 (56.0)

Completed treatment (if ever treated for TB)

Yes

12 (100)

7 (100)

5 (100)

  1. TB tuberculosis, ARV antiretroviral, MTB/RIF Mycobacterium tuberculosis/resistance to rifampicin, a1 missing value; b2 missing values